Form 4: Fractyl Health CEO Buys 10,416 Shares in Private Placement

Fractyl Health's CEO, Harith Rajagopalan, acquired 10,416 shares of common stock at $1.92 per share through a private placement.

Summary

• Harith Rajagopalan, Chief Executive Officer and Director of Fractyl Health, Inc. (GUTS), purchased 10,416 shares of common stock.
• The transaction occurred on December 4, 2025, at a price of $1.92 per share.
• This purchase was made directly from the Issuer in a private placement, which is exempt from Section 16(b) in accordance with Rule 16b-3(d)(1).
• Following this transaction, Mr. Rajagopalan directly owns 501,745 shares of common stock.
• He also indirectly beneficially owns 292,171 shares via the 2021 Irrevocable Trust, 292,170 shares via the 2016 Irrevocable Trust, and 18,639 shares via the 2021 Family Trust.

Sentiment

Score: 7

Explanation: The CEO's direct purchase of company stock, even through a private placement, typically signals strong confidence in the company's future performance and valuation, which is a positive indicator for investors.

Positives

• The CEO's direct purchase of company shares indicates strong confidence in the company's future prospects and valuation.
• Insider buying, especially by a top executive, is often viewed by the market as a positive signal, suggesting management believes the stock is undervalued or expects positive developments.

Negatives

• The purchase was part of a private placement, which, while common, could imply the company sought to raise capital directly from insiders rather than through open market transactions.

Future Outlook

The filing does not contain specific forward-looking statements or guidance, focusing solely on a past insider transaction.

Industry Context

Insider purchases, especially by a CEO, are often viewed by the market as a strong signal of management's belief in the company's undervaluation or robust future prospects. This can be particularly impactful in the biotechnology or healthcare industry, where investor confidence in leadership and strategic direction is crucial.

Related Party Transactions

• The CEO, Harith Rajagopalan, purchased shares directly from Fractyl Health, Inc. in a private placement. This constitutes a related party transaction as it involves a key executive and the company.

Stakeholder Impact

• Shareholders: May interpret the CEO's purchase as a positive signal of confidence in the company's future, potentially influencing stock price positively.
• Employees: Could view the CEO's personal investment as a sign of stability and belief in the company's long-term vision and strategic direction.

Key Dates

Recommendation

The CEO's direct purchase of company stock demonstrates strong insider confidence, which is generally a positive signal. However, without additional financial context from broader filings, this single transaction primarily reinforces a 'hold' position for existing investors and suggests further due diligence for potential new investors rather than an immediate 'buy' or 'sell' recommendation.

Keywords

Fractyl Health, GUTS, Harith Rajagopalan, Insider Trading, CEO Stock Purchase, Private Placement, SEC Form 4, Beneficial Ownership, Common Stock